BCR-ABL1 Quantitative p210p190p230
Introduction to the BCR-ABL1 Quantitative Test
The BCR-ABL1 Quantitative p210p190p230 test is a pivotal diagnostic tool used primarily in the detection and monitoring of chronic myeloid leukemia (CML) and other related genetic disorders. This test measures the quantity of BCR-ABL1 fusion gene transcripts in the blood or bone marrow, which are indicative of the presence of CML. Accurate measurement of these transcripts is crucial for assessing the effectiveness of treatment and determining the prognosis of the disease.
What the Test Measures
This test specifically detects and quantifies the BCR-ABL1 fusion gene transcripts, particularly the p210, p190, and p230 variants. These genetic markers are produced as a result of a chromosomal translocation and are associated with the pathogenesis of CML. By quantifying these transcripts, healthcare providers can ascertain the disease burden and monitor treatment response.
Who Should Consider This Test?
Individuals who may need to undergo the BCR-ABL1 Quantitative test include:
- Patients diagnosed with chronic myeloid leukemia (CML)
- Individuals experiencing symptoms such as fatigue, unexplained weight loss, fever, or splenomegaly
- Those with a family history of genetic disorders related to blood cancers
- Patients undergoing treatment for CML to monitor therapeutic effectiveness
Benefits of Taking the Test
The BCR-ABL1 Quantitative test offers numerous benefits, including:
- Accurate diagnosis of CML and related conditions
- Monitoring of treatment efficacy and disease progression
- Guidance for potential changes in treatment strategies
- Enhanced understanding of individual prognosis based on genetic markers
Understanding Your Results
Results from the BCR-ABL1 Quantitative test are typically reported as a numerical value indicating the quantity of BCR-ABL1 transcripts present. A higher transcript level may indicate a greater disease burden or a response to treatment. It is essential to discuss your results with your healthcare provider to understand their implications fully and decide on the next steps in your treatment plan.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| BCR-ABL1 Quantitative p210p190p230 | 180,000 NGN | 240,000 NGN |
Booking the Test
To book the BCR-ABL1 Quantitative p210p190p230 test, please contact us at +2348110567037. Note that a doctor’s prescription is required for this test, except for cases involving surgery, pregnancy, or individuals planning to travel abroad. Our turnaround time for results is typically 3-4 days.
Sample Type and Pre-Test Instructions
The sample for this test can be obtained from either bone marrow or peripheral blood, which should be transported immediately to ensure accurate results. Patients are advised to follow all pre-test instructions provided by their healthcare provider.
Specialty and Method
This test falls under the specialty of General Physician and employs the Real Time PCR method for accurate and reliable results. It is essential for genetic analysis and monitoring of hematological diseases.
